col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


48 Ergebisse       Seite 1

 [1] 
Medical Informational Agency Publishers: Clinical Medicine (Russian Journal)
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―09 Epidemiological study of the impact of COVID-19 on the course of myocardial infarction S. A. Okrugin, A. N. Repin
2 [GO] 2025―Mrz―12 Celen-Gellerstedt syndrome with the development of microhemorrhages in the lungs after reinfection with SARS-CoV-2 L. P. Romanova, O. V. Alpidovskaya, O. I. Moskovskaya, S. V. Lezhenina, A. V. Moskovsky
3 [GO] 2025―Mrz―12 Respiratory outcomes and predictors of respiratory failure development during surgical myocardial revascularisation in patients who underwent COVID-19 V. S. Ermakov, V. N. Kravchuk, O. Ya. Porembskaya
4 [GO] 2025―Feb―07 Nodular goiter and anamnesis of COVID-19: clinical and pathogenetic relationships, sonographic and cytological features A. I. Nekrasov, I. G. Pochinka, L. G. Strongin, N. Yu. Orlinskaya, L. A. Lugovaya, O. V. Melnichenko
5 [GO] 2025―Feb―07 A case of COVID-19 infection, complicated by viral covid pneumonia, spontaneous rupture in the thinned part of a chronic aneurysm, with type 2 myocardial infarction O. V. Alpidovskaya, N. E. Himaldinova, L. P. Romanova
6 [GO] 2025―Feb―07 Pathogenesis of nervous system lesions and clinical syndromes of the new coronavirus infection COVID-19 M. B. Patsenko, V. L. Glotko, E. A. Shirokov, I. N. Gaivoronskii
7 [GO] 2024―Nov―21 Procalcitonin in new coronavirus infection (COVID-19), complicated by pneumonia, sepsis, in patients with diabetes mellitus E. A. Titova, T. A. Lysenko, A. G. Koblov
8 [GO] 2024―Nov―21 Autonomic dysfunction syndrome in patients with consequences of a new coronavirus infection in outpatient practice E. A. Antipenko, A. V. Shulyndin, A. S. Muromtsev
9 [GO] 2024―Jul―26 Diagnosis and treatment of acute appendicitis in patients with the new coronavirus infection COVID-19 A. A. Kaverina, S. A. Vavrinchuk, P. M. Kosenko
10 [GO] 2024―Jul―26 A decrease in the concentration of free blood glutathione in the acute phase of coronavirus infection L. A. Kolevatova, Yu. V. Ovchinnikov, N. I. Gulyaev, A. A. Prokhorchik, L. L. Euro
11 [GO] 2024―Jun―02 COVID-19 and diabetes: health risks E. S. Sokolova, M. A. Palamarenko, A. A. Osipov, A. M. Chaulin, E. V. Eliseeva, E. S. Koryakin
12 [GO] 2024―Mai―09 Dynamics of clinical and echocardiographic parameters of patients with cardiovascular diseases 3, 12 and 26 months after COVID-19 pneumonia E. I. Yaroslavskaya, V. D. Garanina, N. E. Shirokov, D. V. Krinochkin, N. A. Osokina, I. O. Korovina, et al. (+3)
13 [GO] 2024―Apr―15 AL-amyloidosis after coronavirus infection with acute atypical heart injury Yu A. Lutokhina, O. V. Blagova, D.  Kh. Ainetdinova, N.  D. Sarkisova, E. A. Kogan, V. V. Rameev
14 [GO] 2024―Feb―23 Novel coronavirus infection (COVID-19) - clinical recommendations A. A. Zaitsev
15 [GO] 2024―Feb―23 On the impact of the COVID-19 pandemic on the incidence of community-acquired pneumonia on the example of the region of the European North of Russia T. A. Karapetyan, N. V. Dorshakova, I. V. Peshkova
16 [GO] 2024―Feb―23 Factors of poor prognosis for new coronavirus infection in patients with cardiovacular pathology L. Yu. Eliseeva, N. Yu. Borovkova, P. S. Zubeev, G. N. Zubeeva, E. S. Yumanova
17 [GO] 2024―Feb―23 A case of death in a patient with Marfan syndrome after re-infection with SARS-CoV-2 O. V. Alpidovskaya
18 [GO] 2024―Feb―23 Treatment of heart rhythm disturbances associated with SARS-CoV-2 infection with anti-inflammatory drugs Z. N. Sukmarova, E. G. Zotkin
19 [GO] 2023―Nov―14 Comparative characteristics of the clinical course of a new coronavirus infection depending on the vaccination status S. A. Sokotun, A. I. Simakova, N. G. Plekhova, A. O. Mikhailov, M. D. Barbashev, D. Yu. Barbasheva, et al. (+2)
20 [GO] 2023―Jun―01 Clinical case of methotrexate overdose, the peculiarity of diagnostics in the conditions of the COVID-19 pandemic I. V. Zaborskikh, V. B. Simonenko, S. Kh. Sarmanaev, R. R. Tuktarova, Yu. O. Yurina
21 [GO] 2023―Apr―13 Prevalence of cardiovascular pathology and relationship of left ventricular global longitudinal strain three months after COVID-19 D. V. Krinochkin, E. I. Yaroslavskaya, N. E. Shirokov, E. A. Gorbatenko, E. P. Gultyaeva, I. R. Krinochkina, et al. (+4)
22 [GO] 2023―Apr―13 Analysis of the course and outcomes of COVID-19 in HIV infected patients according to the infectious diseases’ hospital of Moscow M. V. Nagibina, N. A. Smirnov, T. P. Bessarab, N. N. Martynova, A. I. Mazus, S. V. Krasnova, et al. (+2)
23 [GO] 2023―Apr―13 Organization of a system for providing medical care to patients with a new coronavirus infection in Central Clinical Hospital named after P.V. Mandrykа A. V. Demyanenko, N. A. Varavin
24 [GO] 2023―Mrz―27 Arterial hypertension in COVID-19 А. S. Zmitrukevich, A. E. Mamedova
25 [GO] 2023―Jan―19 The dynamic and structure of mortality from respiratory diseases and COVID-19 in the Russian Federation for 2019-2021 I. V. Samorodskaya, E. V. Bolotova, A. V. Dudnikova
26 [GO] 2022―Okt―31 Сauses, risk factors, diagnostics and treatment of gastrointestinal bleeding in patients with a novel coronavirus infection (COVID-19) A. A. Sheptulin, S. S. Kardasheva, A. A. Kurbatova
27 [GO] 2022―Sep―16 Enhancement the eff ec- tiveness of therapy of the new COVID-19 coronavirus infection using interferon alpha-2b in adults A. V. Mordyk, E. N. Vyzhlova, K. Yu. Samsonov, L. A. Zenkova, A. O. Ptukhin, V. V. Kukhlov, et al. (+3)
28 [GO] 2022―Sep―16 The COVID-19 pandemic as a consequence of sustainable changes in the planet’s biosphere G. P. Stupakov, N. V. Shcherbinina, E. A. Shirokov
29 [GO] 2022―Jul―22 Phenomenon of reduced blood oxygen saturation in COVID-19 patients after the use of monoclonal antibodies K. V. Zhdanov, K. V. Kozlov, P. I. Miklush, N. I. Lvov, O. V. Maltsev, V. V. Sharabkhanov, et al. (+7)
30 [GO] 2022―Jun―25 The wickedness of coronavirus and its treatment. The intuition or standard? A. N. Chepurnaya, T. Yu. Lekhmus
31 [GO] 2022―Apr―22 Laboratory-instrumental and histological data characteristic of myocardial changes in COVID-19 A. V. Tsokolov, I. B. Iliin, R. H. Umaev, A. V. Vertelkin
32 [GO] 2022―Apr―22 Neuropsychiatric and behavioral disorders in patients with COVID-19 V. V. Rassokhin, N. A. Belyakov, A. A. Yakovlev, O. E. Simakina
33 [GO] 2022―Mrz―05 The risk of cardiac and cerebrovascular complications in patients with concomitant cardiovascular diseases who have had COVID-19 E. S. Klyachina, O. G. Smolenskaya
34 [GO] 2022―Mrz―05 COVID-19: аnalysis of medical death certificate I. V. Samorodskaya, T. K. Chernyavskaya, E. P. Kakorina
35 [GO] 2022―Jan―27 Spontaneous hematomas in COVID-19: causes, clinic, diagnosis and treatment M. V. Nagibinа, A. S. Sycheva, I. A. Koshelev, M. A. Malyavina, A. A. Solodov, A. L. Kebinа, et al. (+4)
36 [GO] 2021―Dez―02 Type IV myocardial infarction associated with acute stent thrombosis in the early period after revascularization in a patient with new coronavirus infection COVID-19 V. N. Ardashev, A. V. Nagovitsyn, N. V. Zakaryan, O. P. Donetskaya, G. E. Kubenskiy, E. B. Molokhoev, et al. (+4)
37 [GO] 2021―Dez―02 Interrelation of global changes in the planet's biosphere with the expansion of viruses and the COVID-19 pandemic E. A. Shirokov
38 [GO] 2021―Sep―20 Pseudomembranous colitis after COVID-19 antibacterial therapy M. A. Skuratova, P. A. Lebedev, Т. V. Larina, A. P. Sokolov, E. A. Voishcheva, P. A. Dulin
39 [GO] 2021―Sep―16 Possi bilities and perspectives of colchicine application in complex therapy in patients with COVID-19 P. A. Lebedev, A. A. Garanin, E. V. Paranina, A. V. Chernyshev, P. A. Dulin
40 [GO] 2021―Sep―16 Pericardial eff usion as a new specifi c symptom of SARS-CoV-2 Z. N. Sukmarova, V. B. Simonenko, F. M. Ibragimova, A. V. Demyanenko
41 [GO] 2021―Jul―03 Features of the psychoemotional state of doctors providing medical care in the context of the COVID-19 pandemic A. A. Litvinova, A. V. Kravtsiva, A. V. Asmolovsky, S. V. Shamatkova
42 [GO] 2021―Jun―05 Compromised liver function in patients with a new coronavirus infection COVID-19 L. Yu. Eliseeva, A. S. Eliseev, N. Yu. Borovkova, A. S. Vasilkova
43 [GO] 2021―Feb―08 The first experience of treatment applied to patients with pulmonary embolism that developed on the COVID-19 background S. A. Fedorov, A. P. Medvedev, A. L. Maksimov, N. Yu. Borovkova, M. B. Sukhanova, V. V. Pichugin, et al. (+3)
44 [GO] 2021―Jan―11 Pathogenetic basis of venous thromboembolic complications as deuteropathies of COVID-19 S. A. Fedorov, A. P. Medvedev, N. Yu. Borovkova, E. V. Taranov
45 [GO] 2020―Nov―26 Experience with the use of glucocorticoids and netakimab in the treatment of patients with COVID-19 in outpatient settings R. Е. Pavlov, S. V. Tsarenko, A. V. Sekinaeva, P. N. Rybin, M. V. Nagibinа, E. V. Soshnikovа, M. S. Klimova
46 [GO] 2020―Nov―26 Hemocoagulation in coronavirus viral disease: analyses of the problem and our opinion I. N. Bokarev, L. V. Popova
47 [GO] 2020―Okt―30 Vasculopathy in patients with severe COVID-19 infection Т. V. Beketova, E. V. Nasonov
48 [GO] 2020―Sep―18 Complications in COVID-19 patients. Suggested mechanisms of correction V. Kh. Khavinson, B. I. Kuznik
 [1] 

48 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec